EUR 0.06
(-5.84%)
Year | Revenue | Revenue Growth |
---|---|---|
2022 | 5.86 Million EUR | 28.7% |
2021 | 4.55 Million EUR | 24.49% |
2020 | 3.65 Million EUR | -22.15% |
2019 | 4.69 Million EUR | 135278.85% |
2018 | 3471.00 EUR | 11.61% |
2017 | 3110.00 EUR | 31.5% |
2016 | 2365.00 EUR | -5.32% |
2015 | 2498.00 EUR | 21.68% |
2014 | 2053.00 EUR | -99.79% |
2013 | 967 Thousand EUR | 196.63% |
2012 | 326 Thousand EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q2 | 2.9 Million EUR | 0.0% |
2022 Q4 | 3.11 Million EUR | 0.0% |
2022 Q2 | 2.74 Million EUR | 0.0% |
2022 FY | 5.86 Million EUR | 28.7% |
2021 Q4 | 2.44 Million EUR | 0.0% |
2021 Q2 | 2.1 Million EUR | 0.0% |
2021 FY | 4.55 Million EUR | 24.49% |
2020 Q2 | 1.72 Million EUR | 0.0% |
2020 FY | 3.65 Million EUR | -22.15% |
2020 Q4 | 1.93 Million EUR | 0.0% |
2019 Q4 | 2.65 Million EUR | 0.0% |
2019 FY | 4.69 Million EUR | 135278.85% |
2019 Q2 | 2.04 Million EUR | 0.0% |
2018 Q2 | 1660.00 EUR | 0.0% |
2018 FY | 3471.00 EUR | 11.61% |
2018 Q4 | 1811.00 EUR | 0.0% |
2017 Q4 | 1466.00 EUR | 0.0% |
2017 FY | 3110.00 EUR | 31.5% |
2017 Q2 | 1644.00 EUR | 0.0% |
2016 Q4 | 1062.00 EUR | 0.0% |
2016 FY | 2365.00 EUR | -5.32% |
2016 Q2 | 1303.00 EUR | 0.0% |
2015 FY | 2498.00 EUR | 21.68% |
2015 Q2 | 1307.00 EUR | 0.0% |
2015 Q4 | 1191.00 EUR | 0.0% |
2014 FY | 2053.00 EUR | -99.79% |
2014 Q4 | 1046.00 EUR | 0.0% |
2014 Q2 | 1007.00 EUR | 0.0% |
2013 Q4 | 498.00 EUR | -99.79% |
2013 FY | 967 Thousand EUR | 196.63% |
2013 Q3 | 241.75 Thousand EUR | 51445.84% |
2013 Q2 | 469.00 EUR | -99.81% |
2013 Q1 | 241.75 Thousand EUR | 0.0% |
2012 FY | 326 Thousand EUR | 0.0% |
2012 Q1 | 81.5 Thousand EUR | 0.0% |
2012 Q2 | 81.5 Thousand EUR | 0.0% |
2012 Q3 | 81.5 Thousand EUR | 0.0% |
2012 Q4 | 241.75 Thousand EUR | 196.63% |
2011 Q4 | 81.5 Thousand EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Crossject Société Anonyme | 145 Thousand EUR | -3942.069% |
Spineway SA | 10.51 Million EUR | 44.282% |
Amplitude Surgical SA | 106.01 Million EUR | 94.472% |
Sartorius Stedim Biotech S.A. | 2.77 Billion EUR | 99.789% |
EssilorLuxottica Société anonyme | 25.39 Billion EUR | 99.977% |
bonyf N.V. | 309.37 Thousand EUR | -1794.471% |